CVI 2020 Webinar Series: Difficult Occluder Cases
November 5, 2020 – November 5, 2021
TARGET AUDIENCE
This activity has been designed to meet the educational needs of cardiologists, surgeons, internists, trainees, investigators, and allied health care workers who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases.
EDUCATIONAL GOAL
The goal of this activity is to provide participants with knowledge and state-of-the-art management information on how to evaluate and treat patients with coronary artery disease, peripheral vascular disease, and valvular, structural heart and arrhythmic heart disease.
LEARNING OBJECTIVES
- Describe best practices for evaluation and treatment of congenital lesions, left atrial appendage closure, and iatrogenic defect
- Identify the optimal imaging methods for pre-procedural and intra-procedural evaluation of therapy
- Describe management approaches for challenges that may occur during occluder therapy
ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.
The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Start Date: November 5, 2020 End Date: November 5, 2021
FEES
There is no registration fee for this activity.
PARTICIPATION REQUIREMENTS
- View webinar
- At the end of the webinar, login to: https://online-med-edu.com/cvi2020/webinar/docases (you are here)
- Complete the Evaluation/Credit Request Form-No credit requests will be accepted after November 5, 2021
- Download or Print Credit Statement
FACULTY AND DISCLOSURES
CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. CMEsolutions has resolved all conflicts of interest prior to this educational activity.
Mario Goessl, MD
Interventional Cardiologist, Allina Health
Minneapolis, MN
Mario Goessl has disclosed the following relevant financial relationship: Abbott Vascular-Advisory Committee, Consultant
Jacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAI, FSCCT
Clinical Professor, Vancouver General Hospital
Vancouver, BC, Canada
Jacqueline Saw has disclosed the following relevant financial relationships: Abbott Vascular-Consultant, Proctor, Speaker; Boston Scientific-Consultant, Proctor; CIHR: Heart and Stroke Foundation-Research Grant; WL Gore, Baylis-Consultant
Rahul P. Sharma, MD, FRACP
Director of Structural Interventions, Stanford Health Care
Stanford, CA
Rahul Sharma has disclosed the following relevant financial relationships: Abbott, Boston Scientific, Edwards Lifescience, Siemens Healthineers-Consultant
Paul Sorajja, MD
Director, Center for Valve and Structural Heart Diseases, Minneapolis Heart Institute at Abbott Northwestern Hospital
Minneapolis, MN
Paul Sorajja has disclosed the following relevant financial relationships: Abbott Vascular-Consultant, Research Grant, Speaker Bureau; Admedus, Teleflex; WL Gore-Consultant; Boston Scientific, Edwards Lifesciences; Medtronic- Consultant, Research Grant
Firas Zahr, MD
Director of interventional Cardiology, Oregon Health and Science University
Portland, OR
Firas Zahr has disclosed the following relevant financial relationship: Edwards Lifesciences, Medtronic-Research Grant
Planner Disclosures
No member of CMEsolutions or Cardiovascular Innovations Foundation has any relevant financial relationships to disclose in regards to this activity.
Off-label Use
This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.
Commercial Support
Commercial Support for this educational activity will be provided by the following:
- Boston Scientific
- Medtronic
- Philips
Privacy Policy
CMEsolutions Privacy and Confidentiality Policy: www.online-med-edu.com/privacypolicy.pdf
CMEsolutions can be contacted at info@cmesolutions.org .